Mizuho's Top Stock Picks For November Revealed
Portfolio Pulse from Benzinga Neuro
Mizuho's equity research team has released its top buy-rated picks for November, including Coterra Energy Inc (CTRA), Merck & Co. (MRK), EyePoint Pharmaceuticals (EYPT), and Intuit (INTU). Despite a Wall Street average rating of 'hold' for Coterra, Mizuho is bullish on the stock. Mizuho is also positive about Merck, EyePoint Pharmaceuticals, and Intuit. The stocks of these four companies are anticipated to see further growth, with Mizuho's analysts offering optimistic projections for each.
November 05, 2023 | 7:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho is bullish on Coterra Energy Inc, despite a Wall Street average rating of 'hold'. The stock is already up about 14% this year.
Mizuho's bullish stance on Coterra Energy Inc, despite a Wall Street average rating of 'hold', could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
EyePoint Pharmaceuticals is on Mizuho's radar, with shares having risen over 120% this year. The company's focus on less frequently administered eye therapies is its unique selling point.
Mizuho's positive outlook on EyePoint Pharmaceuticals, whose shares have risen over 120% this year, could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Intuit is touted as a potential artificial-intelligence winner by Mizuho. The company's defensible business model and its strong track record of growth are noted.
Mizuho's positive outlook on Intuit, touted as a potential artificial-intelligence winner, could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Mizuho is positive about Merck & Co., despite a nearly 7% dip in its stock this year. The company's promising pharmaceutical pipeline is cited as a key growth driver.
Mizuho's positive outlook on Merck & Co., despite a nearly 7% dip in its stock this year, could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100